Literature DB >> 17439758

Invasive breast cancer.

Robert W Carlson1, Benjamin O Anderson, Harold J Burstein, W Bradford Carter, Stephen B Edge, William B Farrar, Lori J Goldstein, William J Gradishar, Daniel F Hayes, Clifford A Hudis, Mohammad Jahanzeb, Britt-Marie Ljung, Krystyna Kiel, Lawrence B Marks, Beryl McCormick, Lisle M Nabell, Lori J Pierce, Elizabeth C Reed, Samuel M Silver, Mary Lou Smith, George Somlo, Richard L Theriault, John H Ward, Eric P Winer, Antonio C Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17439758     DOI： 10.6004/jnccn.2007.0025

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  10 in total

1.  Breast cancer presenting as parotid tumour - first reported case in literature.

Authors:  Rakesh S Ramesh; Suraj Manjunath; Tanveer Hussain Ustad; Saira Pais; K Shivakumar
Journal:  Indian J Surg Oncol       Date:  2010-08-07

2.  Hormonal therapies in young breast cancer patients: when, what and for how long?

Authors:  Alexandre Christinat; Simona Di Lascio; Olivia Pagani
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

3.  Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model.

Authors:  Jennifer Pasquier; Pierre Magal; Céline Boulangé-Lecomte; Glenn Webb; Frank Le Foll
Journal:  Biol Direct       Date:  2011-01-26       Impact factor: 4.540

4.  Protein biomarkers for the early detection of breast cancer.

Authors:  David E Misek; Evelyn H Kim
Journal:  Int J Proteomics       Date:  2011-08-11

5.  18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.

Authors:  Lanell M Peterson; Brenda F Kurland; Fengting Yan; Alena Novakova- Jiresova; Vijayakrishna K Gadi; Jennifer M Specht; Julie R Gralow; Erin K Schubert; Jeanne M Link; Kenneth A Krohn; Janet F Eary; David A Mankoff; Hannah M Linden
Journal:  J Nucl Med       Date:  2020-06-26       Impact factor: 11.082

6.  Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor α.

Authors:  Silke Kaulfuss; Anna-Maria Herr; Anja Büchner; Bernhard Hemmerlein; Andreas R Günthert; Peter Burfeind
Journal:  Int J Oncol       Date:  2015-05-06       Impact factor: 5.650

7.  Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.

Authors:  Claudia Cava; Gloria Bertoli; Marilena Ripamonti; Giancarlo Mauri; Italo Zoppis; Pasquale Anthony Della Rosa; Maria Carla Gilardi; Isabella Castiglioni
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

8.  Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy.

Authors:  Ling-Li Huang; Ling-Wei Huang; Lei Wang; Ben-Ding Tong; Qing Wei; Xuan-Sheng Ding
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

9.  Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.

Authors:  Allison W Kurian; Daphne Y Lichtensztajn; Theresa H M Keegan; Rita W Leung; Sarah J Shema; Dawn L Hershman; Lawrence H Kushi; Laurel A Habel; Tatjana Kolevska; Bette J Caan; Scarlett L Gomez
Journal:  Breast Cancer Res Treat       Date:  2012-11-09       Impact factor: 4.624

10.  The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer.

Authors:  Cem Onal; Alper Findikcioglu; Ozan Cem Guler; Mehmet Reyhan
Journal:  Breast       Date:  2020-10-26       Impact factor: 4.380
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.